Glass Lewis recommends Masimo investors elect Politan candidates to board
NEW YORK, July 12 (Reuters) -Proxy advisory firm Glass Lewis recommends that Masimo shareholders elect activist investor Politan's two proposed candidates to the medical device maker's five-member board, according to a report reviewed by Reuters.
"We believe investors should endorse the election of (William) Jellison and (Darlene) Solomon at this time," the report said, arguing the current board is to blame for failures at the company, including its tumbling stock price.
"The existing board remains obdurately committed to legacy oversight methodologies which have consistently enabled and amplified poor governance architecture, wide operational misses, nil-return strategic excursions, seemingly de minimis accountability and, ultimately, a lax commitment to acknowledging and addressing profound damage to shareholder value," the report said.
This marks the second time in two years that Politan has proposed board candidates. Last year shareholders elected its two suggested directors, including the firm's founder, hedge fund manager Quentin Koffey.
Masimo's stock price has tumbled 24% over the last 52 weeks.
Glass Lewis and its bigger rival Institutional Shareholder Services influence how investors vote on critical issues including proposed mergers and who sits on the board with their recommendations. ISS has not yet issued its report on Masimo.
Shareholders will vote on July 25 unless the two sides find a compromise beforehand.
Reporting by Svea Herbst-Bayliss; Editing by David Holmes
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
